Engenetiq Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Engenetiq General Information

Description

Operator of a biotechnology company intended to develop Deoxyribonucleic Acid (DNA) and Ribonucleic Acid (RNA) extraction methods. The company specializes in genetics, bioinformatics, molecular biology, and cell biology, providing users with procedures of genetic mapping and population planning more accessible.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Rua Casa do Ator, 1117
  • Vila Olimpia, CEP: 04.546-004
  • Sao Paulo
  • Brazil
Primary Industry
Biotechnology
Corporate Office
  • Rua Casa do Ator, 1117
  • Vila Olimpia, CEP: 04.546-004
  • Sao Paulo
  • Brazil

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Engenetiq Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 22-Mar-2024 Completed Out of Business
1. Seed Round 01-Jan-2022 Completed Generating Revenue
To view Engenetiq’s complete valuation and funding history, request access »

Engenetiq FAQs

  • When was Engenetiq founded?

    Engenetiq was founded in 2017.

  • Where is Engenetiq headquartered?

    Engenetiq is headquartered in Sao Paulo, Brazil.

  • What industry is Engenetiq in?

    Engenetiq’s primary industry is Biotechnology.

  • Is Engenetiq a private or public company?

    Engenetiq is a Private company.

  • What is Engenetiq’s current revenue?

    The current revenue for Engenetiq is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process